Although MYCN is more commonly deregulated in human solid tumors (especially for childhood onset) (36), it has also been reported translocated in human lymphomas (39, 40), mouse plasma cell tumors (41, 42), and, importantly, expressed in the very few human BL cases apparently lacking MYC deregulation (43, 44). This evidence concerns the gene MYCN and plasma cell neoplasm.